Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 2;16(12):e0260397.
doi: 10.1371/journal.pone.0260397. eCollection 2021.

Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season

Guillermo Mena  1   2 , Irma Casas  1   2 , Cristina Casañ  3 , Mario Auñón  1 , Lurdes Matas  2   3   4 , Josep-Maria Mòdol  2   5 , María Esteve  1   2
Affiliations

Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season

Guillermo Mena et al. PLoS One. .

Erratum in

Abstract

Introduction: Influenza vaccination rates in risk groups remain suboptimal. Evidence supporting a significant association between influenza vaccination and severe illness is limited.

Methods: We retrospectively analyzed the epidemiological characteristics of out- and inpatients with laboratory-confirmed influenza infection attended during the 2018-19 epidemic season. Influenza vaccination coverage by indication was analyzed. Logistic regression was used to compare the odds of vaccination between severe and non-severe influenza-positive patients. Severe cases were defined as presenting pneumonia, admission to critical care units and/or death.

Results: The overall vaccination coverage among influenza-positive patients was 30.4%. In subjects with ≥ 1 indication for vaccination, the vaccination coverage was 42.4%. By indication, coverage rates were: 52.5% in patients aged ≥ 59 years, 42.2% in obese patients, 29.2% in immunosuppressed subjects and 6.5% in pregnant women. In patients with underlying chronic diseases, a higher coverage was found in patients with cognitive impairment (77%), muscular dystrophy (63.6%) and renal disease (60.4%). The multivariate logistic regression model showed severe influenza-related illness was associated with a lack of influenza vaccination before seeking care during the 2018-2019 season [0.59 (95%CI 0.36-0.97); p = 0.038], older age [1.01 (95%CI 1.00-1.02); p = 0.009] and current or former smoking status [1.63 (95%CI 0.84-3.18) and 2.03 (95%CI 1.16-3.57); p = 0.031], adjusted by underlying disease.

Conclusion: Adjusting by age, smoking status and underlying disease, a moderate association between the influenza vaccine and severe laboratory-confirmed influenza-related illness was found in an epidemic season in which there was matching between the vaccine and circulating strains. Protection against complications, especially in older subjects and in those with underlying disease is postulated as one of the strengths of annual influenza vaccination. However, influenza vaccination is a pending issue in these groups, especially in pregnant women and obese people. To avoid suboptimal vaccination coverages, health professionals should recommend the seasonal influenza vaccination according to the annual instructions of the health authorities.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Influenza virus types/subtypes detected by epidemiological week at the GTiPUH laboratory during the 2018–2019 influenza season.
See this image and copyright information in PMC

References

    1. World Health Organization. Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. Available at: http://www.who.int/mediacentre/news/releases/2017/seasonal-flu/en/. [Accessed 2020 Jun 17]
    1. Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd. The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses. 2017;11:372–393 doi: 10.1111/irv.12470 - DOI - PMC - PubMed
    1. Jané M, Vidal MJ, Soldevila N, Romero A, Martínez A, Torner N, et al. Epidemiological and clinical characteristics of children hospitalized due to influenza A and B in the south of Europe, 2010–2016. Sci Rep. 2019. Sep 6;9(1):12853 doi: 10.1038/s41598-019-49273-z - DOI - PMC - PubMed
    1. Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, et al. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis. PLoS Med. 2016;13:e1001977 doi: 10.1371/journal.pmed.1001977 - DOI - PMC - PubMed
    1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al.; Global Seasonal Influenza-associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modeling study. Lancet. 2018;391(10127):1285–1300 doi: 10.1016/S0140-6736(17)33293-2 - DOI - PMC - PubMed

MeSH terms

Substances